BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lee II, Kim JJ. Influence of AKT on progesterone action in endometrial diseases. Biol Reprod 2014;91:63. [PMID: 25100707 DOI: 10.1095/biolreprod.114.119255] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 3.6] [Reference Citation Analysis]
Number Citing Articles
1 Pu H, Wen X, Luo D, Guo Z. Regulation of progesterone receptor expression in endometriosis, endometrial cancer, and breast cancer by estrogen, polymorphisms, transcription factors, epigenetic alterations, and ubiquitin-proteasome system. J Steroid Biochem Mol Biol 2022;:106199. [PMID: 36191723 DOI: 10.1016/j.jsbmb.2022.106199] [Reference Citation Analysis]
2 Wright RHG, Vastolo V, Oliete JQ, Carbonell-caballero J, Beato M. Global signalling network analysis of luminal T47D breast cancer cells in response to progesterone. Front Endocrinol 2022;13:888802. [DOI: 10.3389/fendo.2022.888802] [Reference Citation Analysis]
3 Dabi Y, Suisse S, Jornea L, Bouteiller D, Touboul C, Puchar A, Daraï E, Bendifallah S. Clues for Improving the Pathophysiology Knowledge for Endometriosis Using Serum Micro-RNA Expression. Diagnostics 2022;12:175. [DOI: 10.3390/diagnostics12010175] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Smieszek A, Marcinkowska K, Pielok A, Sikora M, Valihrach L, Carnevale E, Marycz K. Obesity affects mitochondrial metabolism and proliferative potential of equine endometrial progenitor cells.. [DOI: 10.1101/2021.12.02.470884] [Reference Citation Analysis]
5 Peluso JJ, Pru JK. Progesterone Receptor Membrane Component (PGRMC)1 and PGRMC2 and Their Roles in Ovarian and Endometrial Cancer. Cancers (Basel) 2021;13:5953. [PMID: 34885064 DOI: 10.3390/cancers13235953] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
6 Arosh JA, Lee J, Banu SK. Effects of dual inhibition of AKT and ERK1/2 pathways on endometrial pro-inflammatory, hormonal, and epigenetic microenvironment in endometriosis. Mol Cell Endocrinol 2021;539:111446. [PMID: 34478807 DOI: 10.1016/j.mce.2021.111446] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Hossain MM, Nakayama K, Shanta K, Razia S, Ishikawa M, Ishibashi T, Yamashita H, Sato S, Iida K, Kanno K, Ishikawa N, Kiyono T, Kyo S. Establishment of a Novel In Vitro Model of Endometriosis with Oncogenic KRAS and PIK3CA Mutations for Understanding the Underlying Biology and Molecular Pathogenesis. Cancers (Basel) 2021;13:3174. [PMID: 34202354 DOI: 10.3390/cancers13133174] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
8 Crosby DA, Glover LE, Brennan EP, Kelly P, Cormican P, Moran B, Giangrazi F, Downey P, Mooney EE, Loftus BJ, McAuliffe FM, Wingfield M, O'Farrelly C, Brennan DJ. Dysregulation of the interleukin-17A pathway in endometrial tissue from women with unexplained infertility affects pregnancy outcome following assisted reproductive treatment. Hum Reprod 2020;35:1875-88. [PMID: 32614049 DOI: 10.1093/humrep/deaa111] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
9 Deng P, Zhou R, Zhang J, Cao L. Increased Expression of KNSTRN in Lung Adenocarcinoma Predicts Poor Prognosis: A Bioinformatics Analysis Based on TCGA Data. J Cancer 2021;12:3239-48. [PMID: 33976733 DOI: 10.7150/jca.51591] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
10 Shen HH, Zhang T, Yang HL, Lai ZZ, Zhou WJ, Mei J, Shi JW, Zhu R, Xu FY, Li DJ, Ye JF, Li MQ. Ovarian hormones-autophagy-immunity axis in menstruation and endometriosis. Theranostics 2021;11:3512-26. [PMID: 33537101 DOI: 10.7150/thno.55241] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 10.0] [Reference Citation Analysis]
11 Wright RHG, Vastolo V, Oliete JQ, Carbonell-caballero J, Beato M. Signalling Network of Breast Cancer Cells in Response to Progesterone.. [DOI: 10.1101/2020.11.03.366401] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Qi H, Liang G, Yu J, Wang X, Liang Y, He X, Feng T, Zhang J. Genome-wide profiling of miRNA expression patterns in tubal endometriosis. Reproduction 2019;157:525-34. [PMID: 30909166 DOI: 10.1530/REP-18-0631] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
13 Poli-Neto OB, Meola J, Rosa-E-Silva JC, Tiezzi D. Transcriptome meta-analysis reveals differences of immune profile between eutopic endometrium from stage I-II and III-IV endometriosis independently of hormonal milieu. Sci Rep 2020;10:313. [PMID: 31941945 DOI: 10.1038/s41598-019-57207-y] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 17.0] [Reference Citation Analysis]
14 Pabona JMP, Burnett AF, Brown DM, Quick CM, Simmen FA, Montales MTE, Liu SJ, Rose T, Alhallak I, Siegel ER, Simmen RC. Metformin Promotes Anti-tumor Biomarkers in Human Endometrial Cancer Cells. Reprod Sci 2020;27:267-77. [PMID: 32046384 DOI: 10.1007/s43032-019-00019-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
15 Liu Y, Lu C, Fan L, Wang J, Li T, Liu Z, Sheng J, Qian R, Duan A, Lu D. MiR-199a-5p Targets ZEB1 to Inhibit the Epithelial-Mesenchymal Transition of Ovarian Ectopic Endometrial Stromal Cells Via PI3K/Akt/mTOR Signal Pathway In Vitro and In Vivo. Reprod Sci 2020;27:110-8. [PMID: 32046378 DOI: 10.1007/s43032-019-00016-5] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 8.0] [Reference Citation Analysis]
16 Huo X, Sun H, Liu Q, Ma X, Peng P, Yu M, Zhang Y, Cao D, Shen K. Clinical and Expression Significance of AKT1 by Co-expression Network Analysis in Endometrial Cancer. Front Oncol 2019;9:1147. [PMID: 31781484 DOI: 10.3389/fonc.2019.01147] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
17 Madanes D, Bilotas MA, Bastón JI, Singla JJ, Meresman GF, Barañao RI, Ricci AG. PI3K/AKT pathway is altered in the endometriosis patient's endometrium and presents differences according to severity stage. Gynecol Endocrinol 2020;36:436-40. [PMID: 31637941 DOI: 10.1080/09513590.2019.1680627] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
18 Cristina Russu M. Progesterone Resistance and Adult Stem Cells’ Genomic and Epigenetic Changes in the Puzzle of Endometriosis. Molecular Bases of Endometriosis - The Integration Between Research and Clinical Practice 2019. [DOI: 10.5772/intechopen.84203] [Reference Citation Analysis]
19 Matsuzaki S, Pouly JL, Canis M. Reply to the letter from Barra et al. Br J Pharmacol 2018;175:3628-9. [PMID: 29984419 DOI: 10.1111/bph.14390] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Barra F, Ferro Desideri L, Ferrero S. Inhibition of PI3K/AKT/mTOR pathway for the treatment of endometriosis. Br J Pharmacol 2018;175:3626-7. [PMID: 29984446 DOI: 10.1111/bph.14391] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 4.5] [Reference Citation Analysis]
21 Haapalainen AM, Karjalainen MK, Daddali R, Ohlmeier S, Anttonen J, Määttä TA, Salminen A, Mahlman M, Bergmann U, Mäkikallio K, Ojaniemi M, Hallman M, Rämet M. Expression of CPPED1 in human trophoblasts is associated with timing of term birth. J Cell Mol Med 2018;22:968-81. [PMID: 29193784 DOI: 10.1111/jcmm.13402] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
22 Dong J, Jiao Y, Mu W, Lu B, Wei M, Sun L, Hu S, Cui B, Liu X, Chen Z, Zhao Y. FKBP51 decreases cell proliferation and increases progestin sensitivity of human endometrial adenocarcinomas by inhibiting Akt. Oncotarget 2017;8:80405-15. [PMID: 29113312 DOI: 10.18632/oncotarget.18903] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
23 van der Putten LJM, van Hoof R, Tops BBJ, Snijders MPLM, van den Berg-van Erp SH, van der Wurff AAM, Bulten J, Pijnenborg JMA, Massuger LFAG. Molecular profiles of benign and (pre)malignant endometrial lesions. Carcinogenesis 2017;38:329-35. [PMID: 28203752 DOI: 10.1093/carcin/bgx008] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
24 Chae U, Min JY, Kim SH, Ihm HJ, Oh YS, Park SY, Chae HD, Kim CH, Kang BM. Decreased Progesterone Receptor B/A Ratio in Endometrial Cells by Tumor Necrosis Factor-Alpha and Peritoneal Fluid from Patients with Endometriosis. Yonsei Med J 2016;57:1468-74. [PMID: 27593876 DOI: 10.3349/ymj.2016.57.6.1468] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
25 van Gent MD, Nicolae-Cristea AR, de Kroon CD, Osse EM, Kagie MJ, Trimbos JB, Hazelbag HM, Smit VT, Bosse T. Exploring Morphologic and Molecular Aspects of Endometrial Cancer Under Progesterone Treatment in the Context of Fertility Preservation. Int J Gynecol Cancer 2016;26:483-90. [PMID: 26825822 DOI: 10.1097/IGC.0000000000000629] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
26 Nastou KC, Tsaousis GN, Papandreou NC, Hamodrakas SJ. MBPpred: Proteome-wide detection of membrane lipid-binding proteins using profile Hidden Markov Models. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 2016;1864:747-54. [DOI: 10.1016/j.bbapap.2016.03.015] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
27 Nastou KC, Tsaousis GN, Papandreou NC, Hamodrakas SJ. MBPpred: Proteome-wide detection of membrane lipid-binding proteins using profile Hidden Markov Models.. [DOI: 10.1101/034942] [Reference Citation Analysis]
28 Pineda MJ, Lu Z, Cao D, Kim JJ. Influence of Cancer-Associated Endometrial Stromal Cells on Hormone-Driven Endometrial Tumor Growth. Horm Cancer 2015;6:131-41. [PMID: 25976290 DOI: 10.1007/s12672-015-0223-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
29 Carp HJA, Soriano D, Zolti M. Progestogens and Endometriosis. Progestogens in Obstetrics and Gynecology 2015. [DOI: 10.1007/978-3-319-14385-9_9] [Reference Citation Analysis]